Objectives: The efficacy of endovascular aneurysm repair (EVAR) against abdominal aortic aneurysm (AAA) in younger patients remains unknown. Hence, the current study aimed to investigate whether the aneurysm-related mortality rate of EVAR is acceptable among patients aged ≤70 years. Methods: Among 644 patients, 148 underwent EVAR (EVAR group), and 496 received open surgical repair (OSR group). The cumulative incidence rates of aneurysm-related death, any intervention, and serious aneurysm-related events after AAA repair were evaluated using the cumulative incidence function in the presence of competing risks. Results: The EVAR group had higher prevalences of several comorbidities, and overall survival for the EVAR group was significantly inferior to that of the OSR group. The cumulative incidence rates of aneurysm-related death, any intervention, and serious aneurysm-related events at 5 years were 1.5%, 11.7%, and 6.4% in the EVAR group and 1.3%, 5.3%, and 5.9% in the OSR group, respectively. EVAR was not a significant prognostic factor of aneurysm-related mortality and serious aneurysm-related events. However, it was an independent poor prognostic factor of any intervention. Conclusion: EVAR was not a significant prognostic factor of aneurysm-related mortality and serious aneurysm-related events. Therefore, it demonstrated acceptable procedure-related long-term outcomes, at least in high-risk young patients.
{"title":"Long-Term Outcomes of Endovascular Aneurysm Repair in Patients Aged ≤70 Years.","authors":"Toshihiro Onohara, Nobuhiro Handa, Masakazu Kawasaki, Fuminori Kasashima, Tetsuya Saito, Teruya Nakamura, Dai Une, Mikizo Nakai, Suguru Shiraya, Kazuki Maeda, Katsuhiko Imai, Tsuyoshi Yamamoto, Yasushi Shimoe, Minoru Okamoto, Yoshikazu Kawazu","doi":"10.3400/avd.oa.23-00072","DOIUrl":"https://doi.org/10.3400/avd.oa.23-00072","url":null,"abstract":"<p><p><b>Objectives:</b> The efficacy of endovascular aneurysm repair (EVAR) against abdominal aortic aneurysm (AAA) in younger patients remains unknown. Hence, the current study aimed to investigate whether the aneurysm-related mortality rate of EVAR is acceptable among patients aged ≤70 years. <b>Methods:</b> Among 644 patients, 148 underwent EVAR (EVAR group), and 496 received open surgical repair (OSR group). The cumulative incidence rates of aneurysm-related death, any intervention, and serious aneurysm-related events after AAA repair were evaluated using the cumulative incidence function in the presence of competing risks. <b>Results:</b> The EVAR group had higher prevalences of several comorbidities, and overall survival for the EVAR group was significantly inferior to that of the OSR group. The cumulative incidence rates of aneurysm-related death, any intervention, and serious aneurysm-related events at 5 years were 1.5%, 11.7%, and 6.4% in the EVAR group and 1.3%, 5.3%, and 5.9% in the OSR group, respectively. EVAR was not a significant prognostic factor of aneurysm-related mortality and serious aneurysm-related events. However, it was an independent poor prognostic factor of any intervention. <b>Conclusion:</b> EVAR was not a significant prognostic factor of aneurysm-related mortality and serious aneurysm-related events. Therefore, it demonstrated acceptable procedure-related long-term outcomes, at least in high-risk young patients.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 1","pages":"25-33"},"PeriodicalIF":0.8,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11018108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-25Epub Date: 2024-01-17DOI: 10.3400/avd.cr.23-00067
Yuta Yamada, Takao Ohki, Naoki Toya, Eisaku Ito, Hikaru Nakagawa
Thoracic endovascular aortic repair (TEVAR) of acute uncomplicated type B aortic dissection (uTBAD) has been discussed for its potential to prevent future aortic events. We present a fenestrated TEVAR in the case of an 86-year-old man with acute uTBAD with an isolated left vertebral artery (ILVA). The ILVA originated from the distal side of the left subclavian artery, the left subclavian artery, and the intramural hematoma with an ulcer-like projection extended close to the left subclavian artery. We selected a fenestrated stent graft to achieve a proximal healthy landing. This case demonstrates that a fenestrated stent graft for acute uTBAD is useful for preserving arch vessels.
急性无并发症 B 型主动脉夹层(UTBAD)的胸腔内血管主动脉修复术(TEVAR)因其可预防未来主动脉事件的发生而备受关注。我们为一名患有急性 UTBAD 并伴有孤立左侧椎动脉(ILVA)的 86 岁男性患者实施了栅栏式 TEVAR。ILVA起源于左锁骨下动脉远侧、左锁骨下动脉和壁内血肿,其溃疡样突起延伸至左锁骨下动脉附近。我们选择了栅栏式支架移植,以实现近端健康着床。本病例表明,在急性 UTBAD 手术中采用栅栏式支架移植术可有效保留弓状血管。
{"title":"Fenestrated Thoracic Endovascular Repair for Acute Type B Aortic Dissection with Isolated Left Vertebral Artery: A Case Report.","authors":"Yuta Yamada, Takao Ohki, Naoki Toya, Eisaku Ito, Hikaru Nakagawa","doi":"10.3400/avd.cr.23-00067","DOIUrl":"https://doi.org/10.3400/avd.cr.23-00067","url":null,"abstract":"<p><p>Thoracic endovascular aortic repair (TEVAR) of acute uncomplicated type B aortic dissection (uTBAD) has been discussed for its potential to prevent future aortic events. We present a fenestrated TEVAR in the case of an 86-year-old man with acute uTBAD with an isolated left vertebral artery (ILVA). The ILVA originated from the distal side of the left subclavian artery, the left subclavian artery, and the intramural hematoma with an ulcer-like projection extended close to the left subclavian artery. We selected a fenestrated stent graft to achieve a proximal healthy landing. This case demonstrates that a fenestrated stent graft for acute uTBAD is useful for preserving arch vessels.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"17 1","pages":"55-58"},"PeriodicalIF":0.8,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11018099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Due to the potential of thrombus blockage and aneurysm rupture, saphenous veins with varicose veins are not advised for use as bypass grafts. However, if no other autologous vein is accessible for use as a conduit in lower-limb bypass; varicose vein transplants may be employed. Few reports have studied the clinical results of lower-limb bypass using varicose vein grafts. We therefore investigated whether or not acceptable patency rates of varicose vein graft for lower-limb bypass could be achieved. Methods: We performed lower-limb bypass using varicose vein graft on nine limbs from June 2017 to May 2020 and conducted a retrospective analysis of prospectively collected data. Results: Early graft failure following bypass surgery using a varicose vein transplant was not detected, and major complications, such as acute graft occlusion or aneurysm dilatation, were not noted throughout the follow-up period. The primary and secondary patency of varicose vein graft was 70.0% and 100% at 3 years, respectively. Conclusion: The incidence of major problems of the varicose vein transplants does not seem to be higher than with conventional saphenous vein grafts. If there are no other appropriate autologous veins, a varicose vein graft may be useful as a conduit for bypass surgery.
{"title":"Short-Term Results of Varicose Vein Graft Used for Lower-Limb Bypass Surgery.","authors":"Atsushi Guntani, Sho Yamashita, Shinsuke Mii","doi":"10.3400/avd.oa.22-00122","DOIUrl":"https://doi.org/10.3400/avd.oa.22-00122","url":null,"abstract":"<p><p><b>Objective</b>: Due to the potential of thrombus blockage and aneurysm rupture, saphenous veins with varicose veins are not advised for use as bypass grafts. However, if no other autologous vein is accessible for use as a conduit in lower-limb bypass; varicose vein transplants may be employed. Few reports have studied the clinical results of lower-limb bypass using varicose vein grafts. We therefore investigated whether or not acceptable patency rates of varicose vein graft for lower-limb bypass could be achieved. <b>Methods</b>: We performed lower-limb bypass using varicose vein graft on nine limbs from June 2017 to May 2020 and conducted a retrospective analysis of prospectively collected data. <b>Results</b>: Early graft failure following bypass surgery using a varicose vein transplant was not detected, and major complications, such as acute graft occlusion or aneurysm dilatation, were not noted throughout the follow-up period. The primary and secondary patency of varicose vein graft was 70.0% and 100% at 3 years, respectively. <b>Conclusion</b>: The incidence of major problems of the varicose vein transplants does not seem to be higher than with conventional saphenous vein grafts. If there are no other appropriate autologous veins, a varicose vein graft may be useful as a conduit for bypass surgery.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"169-173"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/ed/avd-16-3-oa.22-00122.PMC10539130.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: We aimed to investigate the clinical features of upper extremity deep vein thrombosis (UEDVT). Methods: We retrospectively reviewed the background, thrombus site, treatment, and outcome of 76 UEDVT patients. Results: Of the 76 UEDVT patients, 44 (57.9%) were men, and 51 (67.1%) were complicated by malignancy, 44 (57.9%) had an indwelling central vein (CV) catheter, 8 (10.5%) had concomitant pulmonary embolization (PE), and 33 (43.3%) were symptomatic. Regarding the thrombus site, the right internal jugular vein was the most common, with 30 cases (35.3%). As regards the treatment method, 53 patients (69.7%) received oral anticoagulants. In 2015, when direct oral anticoagulants (DOACs) was covered by insurance, there were 44 UEDVT cases, of which 34 (77.3%) received DOACs. Outcomes at a mean observation period of 37.5±41.5 months included 40 deaths (52.6%) with a mean survival of 16.3±21.3 months. The most common cause of death was malignancy, with 33 cases (82.5%). Conclusion: In the background of UEDVT, the combination of indwelling CV catheter placement and malignancy was frequently observed. While the risk of recurrence or PE complications is low, the prognosis of UEDVT complicated by malignancy is extremely poor.
{"title":"Risk and Prognosis of Upper Extremity Deep Vein Thrombosis.","authors":"Yusuke Endo, Naoki Unno, Naoto Yamamoto, Masaki Sano, Kazuto Katahashi, Takafumi Kayama, Yuta Yamanaka, Hajime Tsuyuki, Hiroya Takeuchi, Kazunori Inuzuka","doi":"10.3400/avd.oa.23-00005","DOIUrl":"10.3400/avd.oa.23-00005","url":null,"abstract":"<p><p><b>Objectives:</b> We aimed to investigate the clinical features of upper extremity deep vein thrombosis (UEDVT). <b>Methods:</b> We retrospectively reviewed the background, thrombus site, treatment, and outcome of 76 UEDVT patients. <b>Results:</b> Of the 76 UEDVT patients, 44 (57.9%) were men, and 51 (67.1%) were complicated by malignancy, 44 (57.9%) had an indwelling central vein (CV) catheter, 8 (10.5%) had concomitant pulmonary embolization (PE), and 33 (43.3%) were symptomatic. Regarding the thrombus site, the right internal jugular vein was the most common, with 30 cases (35.3%). As regards the treatment method, 53 patients (69.7%) received oral anticoagulants. In 2015, when direct oral anticoagulants (DOACs) was covered by insurance, there were 44 UEDVT cases, of which 34 (77.3%) received DOACs. Outcomes at a mean observation period of 37.5±41.5 months included 40 deaths (52.6%) with a mean survival of 16.3±21.3 months. The most common cause of death was malignancy, with 33 cases (82.5%). <b>Conclusion:</b> In the background of UEDVT, the combination of indwelling CV catheter placement and malignancy was frequently observed. While the risk of recurrence or PE complications is low, the prognosis of UEDVT complicated by malignancy is extremely poor.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"200-204"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/d6/avd-16-3-oa.23-00005.PMC10539128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41109504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We defined diabetes mellitus (DM) as the recent use of antidiabetic drugs, fasting blood glucose >126 mg/dL, and/or hemoglobin A1c >6.5% because 2-h plasma glucose level was a more difficult and time-consuming test to perform than evaluating HbA1c level and fasting plasma glucose. Thus, DM was defined as FPG ≥126 mg/dL, previous diagnosis of diabetes made by a medical doctor, current use of antidiabetic medications, and/or HbA1c ≥6.5%.1) We described that chronic kidney disease (CKD) was defined as having an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m. In this study, we presented that a person having eGFR less than 30 mL/min/1.73 m was in the stage of near renal failure (Stages 4 and 5 CKD). Moreover, the prevalence of Stage 4 CKD (GFR: 30–15 mL/min/1.73 m2) was also higher in the Japanese general population than in populations of US (for Japan: 0.20% in 2000–20042); for the US: 0.13% in 1999–20003)). One of the post operative major complications in our study was endothermal heat-induced thrombosis (EHIT); however, to classify the injuries, we used only the Kabnick classification. Previously, the American Venous Forum (AVF) reported combining the Kabnick and Lawrence classification into AVF EHIT classification to properly manage and treat EHIT. So, we reported this study in the same way. The purpose of this study was the effectiveness of endovenous radiofrequency ablation (RFA) for older people. Varicose veins in the lower extremities can affect great and small saphenous veins; however, we did not elaborate that in this study because we clarified our purpose. With growing age, healing becomes a slower process. However, we believe that RFA is a minimally invasive therapy. Therefore, healing might not be affected by age. We appreciate these aspects that you pointed out in our study to improve its quality and applicability. We will investigate the further study based on these indications. Further, we hope that you will report more detailed study for RFA.
{"title":"Reply.","authors":"Kiyoshi Tamura","doi":"10.3400/avd.co.23-01001","DOIUrl":"https://doi.org/10.3400/avd.co.23-01001","url":null,"abstract":"We defined diabetes mellitus (DM) as the recent use of antidiabetic drugs, fasting blood glucose >126 mg/dL, and/or hemoglobin A1c >6.5% because 2-h plasma glucose level was a more difficult and time-consuming test to perform than evaluating HbA1c level and fasting plasma glucose. Thus, DM was defined as FPG ≥126 mg/dL, previous diagnosis of diabetes made by a medical doctor, current use of antidiabetic medications, and/or HbA1c ≥6.5%.1) We described that chronic kidney disease (CKD) was defined as having an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m. In this study, we presented that a person having eGFR less than 30 mL/min/1.73 m was in the stage of near renal failure (Stages 4 and 5 CKD). Moreover, the prevalence of Stage 4 CKD (GFR: 30–15 mL/min/1.73 m2) was also higher in the Japanese general population than in populations of US (for Japan: 0.20% in 2000–20042); for the US: 0.13% in 1999–20003)). One of the post operative major complications in our study was endothermal heat-induced thrombosis (EHIT); however, to classify the injuries, we used only the Kabnick classification. Previously, the American Venous Forum (AVF) reported combining the Kabnick and Lawrence classification into AVF EHIT classification to properly manage and treat EHIT. So, we reported this study in the same way. The purpose of this study was the effectiveness of endovenous radiofrequency ablation (RFA) for older people. Varicose veins in the lower extremities can affect great and small saphenous veins; however, we did not elaborate that in this study because we clarified our purpose. With growing age, healing becomes a slower process. However, we believe that RFA is a minimally invasive therapy. Therefore, healing might not be affected by age. We appreciate these aspects that you pointed out in our study to improve its quality and applicability. We will investigate the further study based on these indications. Further, we hope that you will report more detailed study for RFA.","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"244"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b6/4a/avd-16-3-co.23-01001.PMC10539119.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 64-year-old male patient who presented with symptoms indicative of hemolytic anemia was referred to our hospital. After obtaining the patient's history, it was found that hemolysis occurred 14 years after he underwent ascending aortic replacement for acute type A aortic dissection. Enhanced computed tomography revealed an aortic pseudoaneurysm at the proximal anastomosis, which was thought to be the cause of hemolysis. Furthermore, aortic valve regurgitation and dilatation of the sinus of Valsalva were also found on a transthoracic echocardiogram. Therefore, the Bentall procedure was performed. During the surgery, aortic pseudoaneurysm formation and vascular graft stenosis were observed. The postoperative course was uneventful, and hemolysis diminished soon after the surgery.
{"title":"Hemolytic Anemia Occurring 14 Years after Ascending Aortic Replacement for Acute Type A Aortic Dissection Due to Aortic Pseudoaneurysm Derived from Anastomotic Leakage: A Case Report.","authors":"Keishiro Izaki, Yujiro Kawai, Kanako Kobayashi, Takahito Itoh, Satoshi Ohtsubo","doi":"10.3400/avd.cr.23-00008","DOIUrl":"10.3400/avd.cr.23-00008","url":null,"abstract":"<p><p>A 64-year-old male patient who presented with symptoms indicative of hemolytic anemia was referred to our hospital. After obtaining the patient's history, it was found that hemolysis occurred 14 years after he underwent ascending aortic replacement for acute type A aortic dissection. Enhanced computed tomography revealed an aortic pseudoaneurysm at the proximal anastomosis, which was thought to be the cause of hemolysis. Furthermore, aortic valve regurgitation and dilatation of the sinus of Valsalva were also found on a transthoracic echocardiogram. Therefore, the Bentall procedure was performed. During the surgery, aortic pseudoaneurysm formation and vascular graft stenosis were observed. The postoperative course was uneventful, and hemolysis diminished soon after the surgery.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"226-229"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/bc/avd-16-3-cr.23-00008.PMC10539129.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41116673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: In this study, we aim to assess the efficacy of revision using distal inflow (RUDI) in patients with symptomatic dialysis access-associated steal syndrome (DASS). Materials and Methods: All consecutive patients who were diagnosed with grade 3 or 4 DASS and have undergone RUDI in 4 years were included in this study. Results: In total, 35 patients were included in this study; participants had a mean age of 47.5±7.52 years and 54% (n=19) were males. As per our findings, significant improvement was noted in terms of paresthesia (81.2%, p-value: 0.012), coolness (79.4%, p-value: 0.006), pain (78.1%, p-value: 0.006), discoloration (76.4%, p-value: 0.044), paresis (71.4%, p-value: 0.016), and ulcer healing (50%, p-value: 0.044). Gangrene did not further progress in all patients (n=35). Reduction in fistula flow rate after RUDI was 57.5% (682±121 ml/min, p-value: 0.001). Digital systolic pressure was noted to improve by 71.4% (60±9.2 mmHg, p-value: 0.002) after RUDI. Peak systolic velocity increased in both ulnar (66.1±8.2 cm/s, p-value: 0.04) and radial (64.2±7.6 cm/s, p-value: 0.024) arteries of the wrist. Cumulative patency of RUDI graft was 100%, 91.4%, and 85.7% at 3, 6, and 12 months, respectively. Conclusion: RUDI has resulted in significant improvements in terms of DASS symptoms. Using a native vein as conduit, RUDI should be considered a procedure of choice for patients with high-flow DASS.
{"title":"Efficacy of Revision Using Distal Inflow in Patients with Symptomatic Dialysis Access-Associated Steal Syndrome.","authors":"Rashid Usman, Muhammad Jamil, Rabail Fatima, Minahil Mazhar, Shahid Majeed, Amna Shahab","doi":"10.3400/avd.oa.23-00043","DOIUrl":"https://doi.org/10.3400/avd.oa.23-00043","url":null,"abstract":"<p><p><b>Objectives:</b> In this study, we aim to assess the efficacy of revision using distal inflow (RUDI) in patients with symptomatic dialysis access-associated steal syndrome (DASS). <b>Materials and Methods:</b> All consecutive patients who were diagnosed with grade 3 or 4 DASS and have undergone RUDI in 4 years were included in this study. <b>Results:</b> In total, 35 patients were included in this study; participants had a mean age of 47.5±7.52 years and 54% (n=19) were males. As per our findings, significant improvement was noted in terms of paresthesia (81.2%, p-value: 0.012), coolness (79.4%, p-value: 0.006), pain (78.1%, p-value: 0.006), discoloration (76.4%, p-value: 0.044), paresis (71.4%, p-value: 0.016), and ulcer healing (50%, p-value: 0.044). Gangrene did not further progress in all patients (n=35). Reduction in fistula flow rate after RUDI was 57.5% (682±121 ml/min, p-value: 0.001). Digital systolic pressure was noted to improve by 71.4% (60±9.2 mmHg, p-value: 0.002) after RUDI. Peak systolic velocity increased in both ulnar (66.1±8.2 cm/s, p-value: 0.04) and radial (64.2±7.6 cm/s, p-value: 0.024) arteries of the wrist. Cumulative patency of RUDI graft was 100%, 91.4%, and 85.7% at 3, 6, and 12 months, respectively. <b>Conclusion:</b> RUDI has resulted in significant improvements in terms of DASS symptoms. Using a native vein as conduit, RUDI should be considered a procedure of choice for patients with high-flow DASS.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"205-209"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/df/avd-16-3-oa.23-00043.PMC10539131.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41099190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wafa Iftekhar, Fareed Ahmed Shaikh, Nida Jamil, Hafsa Shaikh
Objectives: Splenic artery pseudoaneurysm is a rare but potentially fatal condition. Early diagnosis and intervention are the key steps in the management of this condition. We have reviewed our institution's 4-year data regarding the presentation and management of this condition. Methods: We conducted a prospective review of the records of 10 patients who presented to our institute from January 2018 to December 2021 with a splenic artery pseudoaneurysm. We found one patient with a true aneurysm, whom we excluded from the study. Results: This study included seven male and two female patients with a mean age of 47.7 years. Six patients presented to the emergency department with bleeding secondary to rupture aneurysm, which is the most common reason for admission. Pancreatitis was found to be the most common cause for splenic artery pseudoaneurysm (five patients). Computed tomography angiogram remained the modality of choice for diagnosing splenic artery pseudoaneurysm. All patients were successfully managed with endovascular intervention. Conclusion: Splenic artery pseudoaneurysm is usually a rare complication of pancreatitis, which is associated with high morbidity and mortality. Timely diagnosis and intervention are the keys to successful management. Endovascular embolization should be the first-line therapy in splenic artery pseudoaneurysm.
{"title":"Managing Splenic Artery Pseudoaneurysms-An Experience from a Developing Country. A Retrospective Review.","authors":"Wafa Iftekhar, Fareed Ahmed Shaikh, Nida Jamil, Hafsa Shaikh","doi":"10.3400/avd.oa.22-00114","DOIUrl":"https://doi.org/10.3400/avd.oa.22-00114","url":null,"abstract":"<p><p><b>Objectives:</b> Splenic artery pseudoaneurysm is a rare but potentially fatal condition. Early diagnosis and intervention are the key steps in the management of this condition. We have reviewed our institution's 4-year data regarding the presentation and management of this condition. <b>Methods:</b> We conducted a prospective review of the records of 10 patients who presented to our institute from January 2018 to December 2021 with a splenic artery pseudoaneurysm. We found one patient with a true aneurysm, whom we excluded from the study. <b>Results:</b> This study included seven male and two female patients with a mean age of 47.7 years. Six patients presented to the emergency department with bleeding secondary to rupture aneurysm, which is the most common reason for admission. Pancreatitis was found to be the most common cause for splenic artery pseudoaneurysm (five patients). Computed tomography angiogram remained the modality of choice for diagnosing splenic artery pseudoaneurysm. All patients were successfully managed with endovascular intervention. <b>Conclusion:</b> Splenic artery pseudoaneurysm is usually a rare complication of pancreatitis, which is associated with high morbidity and mortality. Timely diagnosis and intervention are the keys to successful management. Endovascular embolization should be the first-line therapy in splenic artery pseudoaneurysm.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"195-199"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/52/avd-16-3-oa.22-00114.PMC10539133.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41103246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 65-year-old Japanese man without medical history presented with sudden onset lower abdominal pain to our emergency department. Contrast-enhanced computed tomography (CT) revealed dissections of the inferior mesenteric artery and left renal artery with false lumen thrombosis without aortic dissection. He was immediately hospitalized, and conservative treatment was administered. However, on the third-day post-onset, the patient reported severe upper abdominal pain and contrast-enhanced CT showed a new superior mesenteric artery dissection. He continued to receive conservative treatment, and his symptoms improved. He was discharged after ten days of hospitalization.
{"title":"Sequential Multiple Visceral Artery Dissection within a Short Time, without Aortic Dissection.","authors":"Hiroki Uehara, Masaki Okuyama, Yutaro Oe, Takaki Yoshimura, Takahiro Gunji","doi":"10.3400/avd.cr.23-00024","DOIUrl":"https://doi.org/10.3400/avd.cr.23-00024","url":null,"abstract":"<p><p>A 65-year-old Japanese man without medical history presented with sudden onset lower abdominal pain to our emergency department. Contrast-enhanced computed tomography (CT) revealed dissections of the inferior mesenteric artery and left renal artery with false lumen thrombosis without aortic dissection. He was immediately hospitalized, and conservative treatment was administered. However, on the third-day post-onset, the patient reported severe upper abdominal pain and contrast-enhanced CT showed a new superior mesenteric artery dissection. He continued to receive conservative treatment, and his symptoms improved. He was discharged after ten days of hospitalization.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"214-218"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8d/4e/avd-16-3-cr.23-00024.PMC10539126.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41091672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To the Editor: I read the article titled “Effectiveness of Endovenous Radiofrequency Ablation for Elderly Patients with Varicose Veins of Lower Extremities” by Kiyoshi Tamura et al.1) It was a pleasure to read this manuscript. The authors have displayed great precision in highlighting various aspects. However, I would like to address some misunderstandings that have come to my attention and improvements that can aid in future similar studies. First, there is a discrepancy in defining diabetes mellitus (DM) and chronic kidney disease (CKD) in patients used in the study. Kiyoshi Tamura et al.1) defined DM as the recent use of antidiabetic drugs, fasting blood glucose >126 mg/dL, and/or hemoglobin A1c >6.5%, and although most of the criteria used in the definition adheres to the American Diabetes Association, they can add 2-h plasma glucose level of 200 mg/dL and/or a random plasma glucose of 200 mg/dL. In addition, discrepancy with the use of antidiabetic drugs is not only used in patients with DM but also in prediabetic patients using antidiabetic drugs, as recent studies have shown that oral antidiabetic drugs do assist prediabetics in returning to normoglycemic states.2) Chronic kidney disease was defined as having an estimated glomerular filtration rate less than <30 mL/min/1.73 m; however, a study was conducted to give a definition for chronic kidney disease that can be internationally recognized and implemented according to clinical practice guidelines by the Kidney Disease: Improving Global Outcomes (KDIGO), which states “CKD is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m for 3 months or more, irrespective of cause.2) Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens.” Hence, it would be more appropriate for the study conducted.3) Having a broader and more precise definition for CKD by including a period of time would allow better understanding of CKD present in the persons studied, which can also have effects on complications as a result on the effectiveness of endovenous radiofrequency ablation therapy. One of the postoperative major complications considered in the study was endothermal heat-induced thrombosis (EHIT); however, to classify the injuries they used only the Kabnick classification. For improvement, the American Venous Forum (AVF) and Society for Vascular Surgery combines the Kabnick and Lawrence classification into AVF EHIT classification to properly manage and treat EHIT, and hence, it would have provided a better understanding to the level of degree of injury caused due to EHIT.4) Varicose veins in the lower extremities can affect both great and small saphenous veins; however, in the study they did not elaborate on whether the radiofrequency ablation therapy was done on great or small saphenous veins. Further research on the effectiveness of endovenous radiofrequency ab
{"title":"Comment on: Effectiveness of Endovenous Radiofrequency Ablation for Elderly Patients with Varicose Veins of Lower Extremities.","authors":"Safiyyah Manjra","doi":"10.3400/avd.co.23-00052","DOIUrl":"https://doi.org/10.3400/avd.co.23-00052","url":null,"abstract":"To the Editor: I read the article titled “Effectiveness of Endovenous Radiofrequency Ablation for Elderly Patients with Varicose Veins of Lower Extremities” by Kiyoshi Tamura et al.1) It was a pleasure to read this manuscript. The authors have displayed great precision in highlighting various aspects. However, I would like to address some misunderstandings that have come to my attention and improvements that can aid in future similar studies. First, there is a discrepancy in defining diabetes mellitus (DM) and chronic kidney disease (CKD) in patients used in the study. Kiyoshi Tamura et al.1) defined DM as the recent use of antidiabetic drugs, fasting blood glucose >126 mg/dL, and/or hemoglobin A1c >6.5%, and although most of the criteria used in the definition adheres to the American Diabetes Association, they can add 2-h plasma glucose level of 200 mg/dL and/or a random plasma glucose of 200 mg/dL. In addition, discrepancy with the use of antidiabetic drugs is not only used in patients with DM but also in prediabetic patients using antidiabetic drugs, as recent studies have shown that oral antidiabetic drugs do assist prediabetics in returning to normoglycemic states.2) Chronic kidney disease was defined as having an estimated glomerular filtration rate less than <30 mL/min/1.73 m; however, a study was conducted to give a definition for chronic kidney disease that can be internationally recognized and implemented according to clinical practice guidelines by the Kidney Disease: Improving Global Outcomes (KDIGO), which states “CKD is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m for 3 months or more, irrespective of cause.2) Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens.” Hence, it would be more appropriate for the study conducted.3) Having a broader and more precise definition for CKD by including a period of time would allow better understanding of CKD present in the persons studied, which can also have effects on complications as a result on the effectiveness of endovenous radiofrequency ablation therapy. One of the postoperative major complications considered in the study was endothermal heat-induced thrombosis (EHIT); however, to classify the injuries they used only the Kabnick classification. For improvement, the American Venous Forum (AVF) and Society for Vascular Surgery combines the Kabnick and Lawrence classification into AVF EHIT classification to properly manage and treat EHIT, and hence, it would have provided a better understanding to the level of degree of injury caused due to EHIT.4) Varicose veins in the lower extremities can affect both great and small saphenous veins; however, in the study they did not elaborate on whether the radiofrequency ablation therapy was done on great or small saphenous veins. Further research on the effectiveness of endovenous radiofrequency ab","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"16 3","pages":"242-243"},"PeriodicalIF":0.8,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fc/a3/avd-16-3-co.23-00052.PMC10539115.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41095462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}